To functionally screen for rare modifiers of tumor formation from BL sequencing data, we took advantage of an adoptive transfer strategy utilizing the Eμ-Myc genetically engineered mouse model (GEMM) (Fig. 1a). This evidence concerns the gene MYC and neoplasm.